Search | Search Results | The Henry J. Kaiser Family Foundation

Your Selections:

Results
State Data
Slides

Total Results: 5,402

view as grid
view as list

October 18, 2019 Report

A View from the States: Key Medicaid Policy Changes: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2019 and 2020

This report provides an in-depth examination of the changes taking place in Medicaid programs across the country. The findings are drawn from the 19th annual budget survey of Medicaid officials in all 50 states and the District of Columbia conducted by the Kaiser Family Foundation (KFF) and Health Management Associates (HMA), in collaboration with the National Association of Medicaid Directors (NAMD). This report highlights certain policies in place in state Medicaid programs in FY 2019 and policy changes implemented or planned for FY 2020.

October 18, 2019 Report

50-State Medicaid Budget Survey Archives

This page provides access to the reports stemming from the 50-state Medicaid budget surveys published annually since 2000 by the Kaiser Family Foundation (KFF). It tracks trends in Medicaid spending and enrollment, as well as Medicaid policy actions around eligibility and enrollment, provider rates, provider taxes/fees, premiums and cost-sharing, benefits and pharmacy, long-term care and delivery system and payment reform.

October 18, 2019 Issue Brief

Medicaid Enrollment & Spending Growth: FY 2019 & 2020

This brief analyzes Medicaid enrollment and spending trends for FY 2019 and FY 2020 based on interviews and data provided by state Medicaid directors as part of the 19th annual survey of Medicaid directors in all 50 states and the District of Columbia. States reported declines in Medicaid enrollment and modest growth in total Medicaid spending for state fiscal year (FY) 2019 and budgeted for nearly flat enrollment growth but a return to more typical rates of spending growth for FY 2020.

October 17, 2019 Search Page

Prescription Drugs

Amid heightened public concern, the cost of prescription drugs is the focus of renewed attention by the Trump administration and lawmakers in Congress and state capitals. Proposed actions range from sweeping health care system changes to targeted initiatives that could affect Medicare, Medicaid and private insurance. See KFF’s research, analysis…

October 17, 2019 Slideshow

Ten Charts on Proposals to Lower Medicare Prescription Drug Prices

October 17, 2019 Fact Sheet

ACA Open Enrollment: If You Shop on Private Websites Instead of HealthCare.gov

Marketplace plans can now be sold through private websites, sometimes described as “direct enrollment” sites or “certified enrollment partner” sites. This short fact sheet explains how these sites and the plans they offer may differ from what consumers will find on HealthCare.gov.

October 17, 2019 Fact Sheet

ACA Open Enrollment: If You Buy Health Coverage in the Individual Market

This short explainer provides an overview of open enrollment and the 2020 individual insurance market, including Affordable Care Act (ACA) marketplaces, for consumers who buy their own plans rather than getting insurance through an employer.

October 17, 2019 News Release

Poll: About Half of Public Supports a Ban on Both Flavored and All E-Cigarettes, Though Most Young Adults Are Opposed

With more than 1,000 lung injuries and two dozen deaths nationally associated with vaping and e-cigarettes, a new KFF poll finds a narrow majority (52%) of the public supports a ban on the sale of fruit- and other flavored e-cigarettes, while 44% oppose it. When asked whether all e-cigarettes should…

October 17, 2019 Issue Brief

Data Note: Public Views on Vaping and E-Cigarettes

This polling data note examines the public’s attitudes about e-cigarettes and vaping amid growing concerns about vaping-related lung illnesses and proposals by state and federal government to ban or limit the sale of e-cigarettes. It assesses views towards ban proposals and beliefs about their safety and impact on teenagers.

October 17, 2019 Issue Brief

What’s the Latest on Medicare Drug Price Negotiations?

In response to higher drug spending growth and heightened attention to drug prices, some policymakers have proposed allowing Medicare to negotiate the price of prescription drugs. This issue brief provides a short history of this proposal, describes several bills introduced in the 116th Congress to allow government negotiations as well as assessments of potential savings from the Congressional Budget Office (CBO), and considers the prospects for action in the future.

Refine Results

date

Topics

Content Type

Tags